Election Outlook—Explaining Healthcare Policy Proposals’ Impacts on Innovation and Patients

2:30 PM - 3:25 PM (EST), Monday, February 10, 2020 ・ Lyceum Complex
Polls of U.S. public confidence in prescription drug companies have dropped so far that multiple policy proposals are under consideration that could drastically shrink the investment resources available for innovative medicines, reducing patients’ hopes and raising healthcare costs long-term. Such proposals intersect during an election year likely to be highly volatile as political matters unrelated to healthcare also impact candidates, legislative calendars, and regulatory priorities. This panel will explain and prioritize the policy proposals with greatest impact on biopharmas as well as discuss the opportunities for the industry to communicate the risks of bad policies on pipelines and patients.
Moderator
photo
Senior Healthcare Policy Analyst
Bloomberg Intelligence
Speakers
photo
Head, Client Solutions, Marketing & Ops
Avalere Health
photo
President & CEO
Biotechnology Innovation Organization (BIO)
photo
CEO
Nkarta Therapeutics
photo
President and Chief Executive Officer
Alliance for Aging Research
photo
President and Co-Founder
Center for Medicine in the Public Interest